Publication date: Aug 28, 2024
This chapter summarizes the epidemiological study design of natural immune epidemiology studies based on recent COVID-19-related research. The epidemiological studies on antiviral innate immunity have mainly included randomized controlled trials (RCTs) and observational studies. Importantly, this chapter will discuss how to use these methodologies to answer an epidemiological question of natural immunity in the viral infection process based on previous studies. An observational case- or cohort-based study of antiviral innate immunity may support this theoretical hypothesis but is not appropriate for clinical practice or treatment. RCTs are the gold standard for epidemiological studies and occupy a greater role in the hierarchy of evidence.
Semantics
| Type | Source | Name |
|---|---|---|
| disease | VO | study design |
| disease | MESH | COVID-19 |
| disease | MESH | viral infection |
| disease | IDO | process |
| drug | DRUGBANK | Gold |